XBI

Fund Description
The SPDR S&P Biotech ETF before expenses seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index (ticker: SPSIBITR).
Fund Profile
Fund Name SPDR S&P Biotech ETF
Fund Exchange Ticker XBI
Fund Sponsor State Street (SPDR)
Fund ISIN US78464A8707
Net Expense Ratio 0.35 %
Fund Inception Date 31 January 2006
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name S&P Biotech Index
Index Provider S&P DJ Indices
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 17 January 2019
Asset Under Management 4047.61 Million (USD)
1 Month Total Return 9.81 %
Year To Date Return 14.84 %
1 Year Total Return -6.18 %
3 Year Annualized Total Return 14.65 %
NAV 82.5201
Share Outstanding 49,050,000
Top 10 Holdings (16 January 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
LOXO ONCOLOGY INC LOXO EQUI 0.0210604100
MIRATI THERAPEUTICS INC MRTX EQUI 0.0173502400
SAGE THERAPEUTICS INC SAGE EQUI 0.0165652200
PORTOLA PHARMACEUTICALS INC PTLA EQUI 0.0162394200
CELGENE CORP CELG EQUI 0.0160473200
NEUROCRINE BIOSCIENCES INC NBIX EQUI 0.0154556200
ACADIA PHARMACEUTICALS INC ACAD EQUI 0.0153506000
SEATTLE GENETICS INC SGEN EQUI 0.0148571300
BLUEBIRD BIO INC BLUE EQUI 0.0147947700
FIBROGEN INC FGEN EQUI 0.0145048400